About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« USPTO News: Official Announcement Regarding Restriction Practice in Applications Containing Nucleotide Sequences | Main | No New Abbott Medicines for Thailand »

March 13, 2007

Comments

Why is this news?

Bubba:

Thank you for expressing an interest in our blog. When we began "Patent Docs," one of our stated goals was to "highlight newly issued biotech and pharma patents" (see our first post on October 22, 2006). Our patent profiles constitute one way in which we are attempting to satisfy this goal.

By providing information on selected U.S. patents, it is our hope that "Patent Docs" will help patent professionals stay abreast of the biotech/pharma patent landscape. For example, the '484 patent discussed in the story above relates to liposomal drug delivery, an area of research that has seen quite a bit of recent patent activity. In addition, we believe that our patent profiles provide helpful information regarding the types of claims that the Patent Office is currently allowing. Finally, an analysis of our site stats indicates that most "Patent Docs" readers appear to be interested in the patent profiles.

Again, we thank you for reading our blog, and for taking the time to let us know what you think about "Patent Docs."

Don

The comments to this entry are closed.

April 2024

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30